美国食品和药物管理局授予Chimeric Therapeutics的CDH17细胞治疗胃癌的孤儿药物地位,支持其发展. FDA grants orphan drug status to Chimeric Therapeutics' CDH17 cell therapy for gastric cancer, supporting its development.

食品和药物管理局批准将孤儿药物指定为摇头丸疗法治疗胃癌的CHM CDH17细胞疗法,提供发展奖励和潜在的市场独家性。 The FDA has granted Orphan Drug Designation to Chimeric Therapeutics’ CHM CDH17 cell therapy for gastric cancer, offering development incentives and potential market exclusivity. 该疗法以CDH17表示肿瘤为对象,目前处于前直肠癌试验第1/2阶段,并可能扩大到胃癌。 The therapy, targeting CDH17-expressing tumors, is in a Phase 1/2 trial for advanced colorectal cancer and may expand to gastric cancer. 在此之前,林业发展局支持Imugene现成的CAR T疗法Azer-cel,该疗法获得了拟议的注册路径。 This follows FDA support for Imugene’s off-the-shelf CAR T therapy azer-cel, which received a proposed registration pathway. 与此同时,Kairos Minerals公司与Nyamal土著公司就西澳大利亚的Mt York黄金项目签订了采矿协议,推动土著参与。 Meanwhile, Kairos Minerals secured a mining agreement with the Nyamal Aboriginal Corporation for its Mt York Gold Project in Western Australia, advancing Indigenous engagement. Lindian Resources开始在马拉维的Kangankunde稀土项目钻井, Lindian Resources began drilling at its Kangankunde rare earths project in Malawi, targeting high-grade neodymium–praseodymium zones to support early-stage production.